SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material:
SEC Accession No. 0001399529-21-000076
Filing Date
2021-04-20
Accepted
2021-04-20 16:28:32
Documents
4

Document Format Files

Seq Description Document Type Size
1 DEFA14A drna-2021xdefa14a.htm DEFA14A 29016
2 dicernapharmaceuticalsinc_.jpg GRAPHIC 894496
3 dicernapharmaceuticalsinc_a.jpg GRAPHIC 1227893
4 dicernareports1q191.jpg GRAPHIC 22788
  Complete submission text file 0001399529-21-000076.txt   2981922
Mailing Address 75 HAYDEN AVENUE LEXINGTON MA 02421
Business Address 75 HAYDEN AVENUE LEXINGTON MA 02421 617 621 8097
Dicerna Pharmaceuticals Inc (Filer) CIK: 0001399529 (see all company filings)

IRS No.: 205993609 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEFA14A | Act: 34 | File No.: 001-36281 | Film No.: 21838193
SIC: 2834 Pharmaceutical Preparations